New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
07:34 EDTNAVBNavidea, collaborators announce NAV4694 presentations
Navidea Biopharmaceuticals announced that collaborators from the Department of Nuclear Medicine at University Hospital of Leipzig are planning presentations highlighting Navidea’s PET imaging agent, NAV4694, at the German Society of Nuclear Medicine Annual Congress in Hannover, Germany. NAV4694 is an investigational Fluorine-18 labeled beta-amyloid imaging agent currently being evaluated in late stage clinical trials for use as an aid in differential diagnosis and to monitor progression of Alzheimer's disease, Mild Cognitive Impairment and other forms of neurodegenerative dementia.
News For NAVB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
07:34 EDTNAVBNavidea reiterates FY15 Lymphoseek product revenue view $10M-$12M
Subscribe for More Information
07:34 EDTNAVBNavidea reports Q2 EPS (6c), two estimates (4c)
Subscribe for More Information
July 29, 2015
07:32 EDTNAVBNavidea wins $1.7M fast track NIH SBIR grant for evaluation of RA treatment
Subscribe for More Information
July 28, 2015
07:35 EDTNAVBNavidea, MGH to evaluate Manocept for detection of cardiovascular disease
Subscribe for More Information
July 23, 2015
08:50 EDTNAVBNavidea announces peer-reviewed publication of data on Lymphoseek
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use